Upgrade to SI Premium - Free Trial

Aktis Oncology (AKTS)

23.30 -0.64 (2.67%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

Oppenheimer Starts Aktis Oncology (AKTS) at Outperform September 9, 2026 6:01 AM - StreetInsider Wedbush Starts Aktis Oncology (AKTS) at Outperform August 19, 2026 6:59 AM - StreetInsider BMO Capital Starts Aktis Oncology (AKTS) at Outperform August 18, 2026 4:14 PM - StreetInsider Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026 August 13, 2026 4:01 PM - StreetInsider Leerink Assumes Aktis Oncology (AKTS) at Outperform July 21, 2026 4:49 PM - StreetInsider Aktis Oncology (AKTS) PT Raised to $33 at JPMorgan July 14, 2026 7:42 AM - StreetInsider Raymond James Starts Aktis Oncology (AKTS) at Strong Buy (correction) June 15, 2026 4:08 PM - StreetInsider Full Article List